Page results
-
Two directors have joined the UCLH Board – Liz O’Hara, director of workforce and Laura Churchward, director of strategy.
-
“Vaccines do not kill, the virus does”: that was the message from local leaders from a variety of different faiths during an event at the newly opened vaccination centre at the Business Design Centre in Islington.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
As photographer Tom Pilston searched for a way to make his contribution during the Covid-19 pandemic, he cast around for a project which would allow him to pay tribute to the NHS he describes as "all that is good about the UK ... humane and caring, hard-working, sensitive and strong".
-
The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to a new UCL-led study.
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
-
Dr Hotton is a consultant neurologist with a special interest in movement disorders and the neurological care of patients with central nervous system tumours.
-
This page was written by the Unit of Functional Neurosurgery at the National Hospital for Neurology and Neurosurgery, Queen Square, London, with help from people who suffer from Parkinson Disease (PD).
